Ivabradine inhibition of HCN1 channels. (
A) Traces plot the stimulation protocol used for the study of
I h steady state activation. From a holding of −35 mV, 2-second long voltage steps, ranging from −60 to −120 mV in 10-mV steps, were followed by a 0.5-second step at −70 mV for tail current analysis. (
B,
C) Difference records obtained by subtracting records in the presence of 30 μM ivabradine (
B) or 3 mM CsCl (
C) from their corresponding control records. (
D) Current amplitudes during the last 100 ms of each difference record were converted to conductances and normalized to the value at −120 mV to generate fractional activation curves. Average fractional activation plotted from ivabradine-sensitive (
filled circles) and Cs-sensitive (
open circles) currents. Smooth curves through data points plot best fits by
equation 1 . Ivabradine data points were best fit by the continuous curve using the following parameters:
V 1/2 = −75.3 ± 2.1 mV;
s = 7.6 ± 0.7 mV. CsCl data points were best fit by the dotted curve using the following parameters:
V 1/2 = −75.8 ± 2.3 mV;
s = 5.1 ± 0.6 mV. (
E,
F)
Dotted traces plot on an expanded scale time difference records at −120 mV from (
B) and (
C) in (
E) and (
F), respectively. The smooth continuous lines are best fits of
equation 2to difference records, with time constants of 38 and 33 ms for the ivabradine and the Cs-sensitive currents, respectively.
Horizontal dotted traces were computed as the difference between fit and difference records. (
G) Data points plot average activation time constants as a function of activating voltages from three independent experiments for ivabradine-blocked (
filled circles) and Cs-blocked (
open circles) currents. (
H,
I) The response to a 18.75-second long step at −110 (
H) applied after full
I h inhibition by 30 μM ivabradine is plotted (
I).